EUA
ViraDx SARS-CoV-2/Flu A+B Rapid Antigen Test
FDA Emergency Use Authorization · Princeton BioMeditech Corp. · Oct 23, 2024
Key facts
| Product | ViraDx SARS-CoV-2/Flu A+B Rapid Antigen Test |
|---|---|
| Company | Princeton BioMeditech Corp. |
| Product type | Lateral Flow, Visual Read, Multi-analyte, Single Target |
| Date | Oct 23, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: